Evidence-Based Solutions

King-Devick Test, Inc. offers a broad set of evidence-based solutions utilizing integrated technology for concussion management, reading performance, and as indicators of neurological function. King-Devick Test products have been scientifically validated in more than 60 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation and ALS.

King-Devick Test products are based on the measurement of the speed of rapid number naming (RNN™), reading aloud a series of single digit numbers from left to right and line to line, and the ability to discern various levels of contrast. These tasks detect impairments of eye movements, attention, language, and other correlates of suboptimal brain function.

King-Devick Test in association with Mayo Clinic

In an effort to bring awareness and increase concussion screening, in 2015, Mayo Clinic and King-Devick Test, Inc. announced that they had executed a licensing agreement to co-brand the King-Devick concussion screening test to King-Devick Test in association with Mayo Clinic.

King-Devick Test Today

Learn More ›

King-Devick Test in association with Mayo Clinic

Learn More ›

King-Devick Test History

Learn More ›

King-Devick Test® (K-D Test®) All rights reserved. Copyrighted. ©1983, 2010-2016, Patents-Pending. Mayo and Mayo Clinic are registered trademarks owned by Mayo Foundation for Medical Education and Research. Two Mid America Plaza, Suite 110, Oakbrook Terrace, IL 60181. King-Devick Test is for screening purposes only and any suspicion or indication of head trauma should be evaluated by a licensed professional.